1. Home
  2. MCHX vs CRDL Comparison

MCHX vs CRDL Comparison

Compare MCHX & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCHX
  • CRDL
  • Stock Information
  • Founded
  • MCHX 2003
  • CRDL 2017
  • Country
  • MCHX United States
  • CRDL Canada
  • Employees
  • MCHX N/A
  • CRDL N/A
  • Industry
  • MCHX Business Services
  • CRDL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MCHX Consumer Discretionary
  • CRDL Health Care
  • Exchange
  • MCHX Nasdaq
  • CRDL Nasdaq
  • Market Cap
  • MCHX 84.3M
  • CRDL 105.8M
  • IPO Year
  • MCHX 2004
  • CRDL N/A
  • Fundamental
  • Price
  • MCHX $2.15
  • CRDL $1.31
  • Analyst Decision
  • MCHX
  • CRDL Strong Buy
  • Analyst Count
  • MCHX 0
  • CRDL 3
  • Target Price
  • MCHX N/A
  • CRDL $9.33
  • AVG Volume (30 Days)
  • MCHX 60.2K
  • CRDL 231.5K
  • Earning Date
  • MCHX 08-07-2025
  • CRDL 08-11-2025
  • Dividend Yield
  • MCHX N/A
  • CRDL N/A
  • EPS Growth
  • MCHX N/A
  • CRDL N/A
  • EPS
  • MCHX N/A
  • CRDL N/A
  • Revenue
  • MCHX $47,951,000.00
  • CRDL N/A
  • Revenue This Year
  • MCHX $5.73
  • CRDL N/A
  • Revenue Next Year
  • MCHX N/A
  • CRDL N/A
  • P/E Ratio
  • MCHX N/A
  • CRDL N/A
  • Revenue Growth
  • MCHX N/A
  • CRDL N/A
  • 52 Week Low
  • MCHX $1.26
  • CRDL $0.77
  • 52 Week High
  • MCHX $2.40
  • CRDL $2.63
  • Technical
  • Relative Strength Index (RSI)
  • MCHX 63.09
  • CRDL 48.17
  • Support Level
  • MCHX $2.05
  • CRDL $1.22
  • Resistance Level
  • MCHX $2.30
  • CRDL $1.50
  • Average True Range (ATR)
  • MCHX 0.12
  • CRDL 0.09
  • MACD
  • MCHX 0.01
  • CRDL -0.01
  • Stochastic Oscillator
  • MCHX 60.78
  • CRDL 28.57

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Share on Social Networks: